Life Sciences 1992-01-01

Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.

J E Zadina, A J Kastin, D Kersh, A Wyatt

Index: Life Sci. 51(11) , 869-85, (1992)

Full Text: HTML

Abstract

The brain peptide Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) was tested for its effects on electrically stimulated contractions in the guinea pig ileum assay. Tyr-MIF-1 acted as an opiate agonist in reducing these contractions. Its IC50 was about 9 microM, and its effects were reversed by naloxone and CTOP. The ability of Tyr-MIF-1 also to antagonize the inhibitory effects of opiates on electrically stimulated contractions was more evident in the ileum removed from a guinea pig tolerant to morphine or after partial inactivation of opiate receptors with beta-CNA. Similar results were observed with hemorphin. The endogenous peptide Tyr-MIF-1 and the blood-derived peptide hemorphin, therefore, can act as agonists as well as antagonists in the guinea pig ileum. The effects as antagonists are best observed in preparations of ileum with reduced receptor reserve (tolerant or beta-CNA treated) and are consistent with the idea that properties of endogenous peptides as opiate antagonists are enhanced in the tolerant state.


Related Compounds

Related Articles:

Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.

2000-09-01

[J. Pharmacol. Exp. Ther. 294 , 933, (2000)]

Relationship between kappa 1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes.

1993-01-07

[Biochem. Pharmacol. 45(1) , 207-16, (1993)]

Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding.

2001-09-14

[J. Biol. Chem. 276(37) , 34624-30, (2001)]

Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrain.

2008-03-01

[Eur. Neuropsychopharmacol. 18(3) , 194-9, (2008)]

Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization.

2009-06-03

[J. Neurosci. 29(22) , 7341-8, (2009)]

More Articles...